Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

MEDP

Medpace Holdings, Inc.

Services-Commercial Physical & Biological Research · SIC 8731CIK 1668397Held by 10 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$2.53B
Net Income FY2025
$0.45B
EPS (Basic, as reported)
$15.64
Net Margin FY2025
17.8%
ROE FY2025
98.3%
Total Equity
$0.46B
Shares Out
28M
Business description

Medpace Holdings, Inc. — Services-Commercial Physical & Biological Research. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2015–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 422 → 2,530 +22% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue4224367058619261,1421,4601,8862,1092,530
Selling, general & administrative(62)(63)(76)(95)(92)(108)(131)(161)(180)(198)
Total operating expenses(369)(371)(604)(734)(759)(944)(1,181)(1,549)(1,662)(1,995)
Operating income5265101127167199279337447535
Other income (expense), net(31)(8)(7)(2)134(1)297
Pre-tax income225794125169202283336476542
Income tax expense(9)(18)(21)(24)(23)(20)(37)(53)(72)(91)
Net income133973100145182245283404451
EPS — basic$0.38$1.00$2.05$2.79$4.07$5.06$7.57$9.20$13.06$15.64
EPS — diluted$0.37$0.98$1.97$2.67$3.84$4.81$7.28$8.88$12.63$15.28
Shares outstanding — basic (M)36393636363632313129
Shares outstanding — diluted (M)36403738383834323230

Showing the latest 10 of 11 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.